Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research Read More > February 3, 2021
Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission Read More > February 2, 2021
Increased sensitivity to strong perturbations in a whole-brain model of LSD Read More > January 29, 2021
Psychedelics, placebo effects, and set and setting: Insights from common factors theory of psychotherapy Read More > January 26, 2021
Harmine inhibits the proliferation and migration of glioblastoma cells via the FAK/AKT pathway Read More > January 26, 2021
Within-treatment changes in a novel addiction treatment program using traditional Amazonian medicine Read More > January 25, 2021
Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression Read More > January 22, 2021
Clinically meaningful changes on depressive symptom measures and patient-reported outcomes in patients with treatment-resistant depression Read More > January 22, 2021
Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants Read More > January 20, 2021
Classical Psychedelics as Therapeutics in Psychiatry – Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders Read More > January 20, 2021
